Company profile

Median Technologies

Median Technologies has 1 AI-enabled medical device on the FDA list. The first decision was on February 6, 2026 and the most recent on February 6, 2026 (Median LCS (internal name) / eyonis LCS (trade name) (1.0)). Its most common review panel is Radiology (1 device).

1AI devices
2026First decision
2026Latest decision
1Specialties

Timeline

  1. Median LCS (internal name) / eyonis LCS (trade name) (1.0) · Radiology · QDQ